Surgical Management of Optic Disc Pit Maculaopathy
Study Details
Study Description
Brief Summary
To evaluate the anatomical and functional results of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
As it is well known, optic disc pit (ODP) is a rare congenital disease which is usually associated with maculopathy (ODP-M) in the form of intraretinal and subretinal fluid accumulation at the macular area leading to visual impairment.
With no definite treatment and absence of guidelines for its management, the invistigators considered their prospective, interventional case series to evaluate the anatomical and functional results of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Optic disc pit maculopathy pars plana vitrectomy with internal limiting membrane (ILM) peeling, endolaser |
Procedure: pars plana vitrectomy with internal limiting membrane (ILM) peeling
pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- anatomical improvement [6 months]
Retinal reattachment
Secondary Outcome Measures
- Functional improvement [6 months]
Visual acuity letters gain
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients included in this study are those with ODP associated with macular detachment
Exclusion Criteria:
- Exclusion criteria included patients unfit for general anesthesia, those with insufficient clear media to perform the surgery with ILM peeling and those with other ocular diseases that can affect central macular thickness (CMT) and the best corrected visual acuity (BCVA).
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Minia University
Investigators
- Principal Investigator: Mahmud Genaidy, MD, Assistant professor of ophthalmology, ophthalmology department, Minia university, Egypt
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ODP-M